Bionano Genomics Inc (NASDAQ:BNGO) currently has a daily average trading volume of 1.62M but it saw 1594480 shares traded in last market. With a market cap of 49.95M USD, the company’s current market price of $0.82 came falling about -4.64 while comparing to the previous closing price of $0.86. In past 52 weeks, the stock remained buoying in the range of price level as high as $9.80 and as low as $0.85.
Taking a look at 20-day trading activity of Bionano Genomics Inc (BNGO) gives us an average price of $1.0106, while its current price level is -91.68% below from 52-week high level whereas it is -3.46% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.1061 while that of 200 days or SMA-200 reads an average of $2.3672. A closer look into the stock’s movement over the week reveals that its volatility is standing at 10.65% during that period while stretching the period over a month that decreases to 8.60%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 26.65 which implies that the stock is in oversold territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Scotiabank which initiated the stock as “Sector Outperform” in its note to investors issued on January 05, 2023, recommending a price target of $4 for it. Oppenheimer issued its recommendations for the stock as it resumed the price target for the stock is $12.
Over the week, BNGO’s stock price is moving -21.56% down while it is -20.02% when we observe its performance for the past one month. Year-to-date it is -56.84% down and over the past year, the stock is showing a downside performance of -90.90%.
Currently, Bionano Genomics Inc’s total number of outstanding shares is 61.23M. Company’s return on investment (ROI) stands at -225.00% and return on equity (ROE) at -134.56%. Stock’s beta reads 2.42. Stock has a price to book (P/B) ratio of 0.39 while price to sale or P/S ratio amounts to 1.38. Its return on asset (ROA) is -89.09% on average.
